Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference10 articles.
1. Uterine sarcomas. A retrospective study of 17 cases;Geraci;Eur. J. Gynaecol. Oncol.,1988
2. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium;Marth;Gynecol. Oncol.,1997
3. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer;Bergman;Lancet,2000
4. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer;Curtis;J. Natl. Cancer Inst.,2004
5. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Carcinosarcom uterin – prezentare de caz;Obstetrica şi Ginecologia;2023
2. The valid evidence to reveal the effect of sex hormone on primary retroperitoneal malignant mixed mullerian tumor: a case report;EUR J GYNAECOL ONCOL;2019
3. Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase;Computational and Structural Biotechnology Journal;2019
4. Evolution and Embryonic Development;Evolution's Clinical Guidebook;2019
5. Reinventing Diagnosis;Precision Medicine and the Reinvention of Human Disease;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3